Company news

Co-Diagnostics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

December 9, 2025

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

December 8, 2025

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

November 20, 2025

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

November 18, 2025

Co-Diagnostics Reports Third Quarter 2025 Financial Results

November 13, 2025

Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia

November 12, 2025

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

November 5, 2025

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

November 3, 2025

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

October 31, 2025

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

October 30, 2025

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

October 29, 2025

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

October 28, 2025

Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx™ PCR Platform Across the Middle East

October 27, 2025

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

October 22, 2025

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

October 16, 2025

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

October 13, 2025

Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30

September 30, 2025

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

September 18, 2025

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

September 17, 2025

Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East

September 16, 2025

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains

September 11, 2025

Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

September 9, 2025

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

August 18, 2025

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results

August 14, 2025

Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast

July 31, 2025

Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025

July 15, 2025

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

May 14, 2025

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results

May 8, 2025

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

April 29, 2025

Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

March 27, 2025

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast

March 13, 2025

Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit

March 6, 2025

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

March 3, 2025

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

February 21, 2025

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

December 9, 2024

Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results

November 6, 2024

Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024

November 4, 2024

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast

October 24, 2024

Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024

October 20, 2024

Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test

September 4, 2024

Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results

August 7, 2024

Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast

July 24, 2024

Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States

July 1, 2024

Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform

June 13, 2024

Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results

May 8, 2024

Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast

April 24, 2024

Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event

April 11, 2024

Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions

April 3, 2024

Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results

March 13, 2024

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test

March 6, 2024

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks